P47.07 KEAPSAKE Study of Telaglenastat vs Placebo Plus Standard-of-Care in 1L KEAP1/NRF2-Mutated Non-Squamous Metastatic NSCLC

Spigel, D. R., Akerley, W., Evangelist, M., Johnson, M., Levy, B., Owonikoko, T., Paik, P., Papagiannakopoulos, T., Reckamp, K., Akella, L., Holland, S., Jenkins, Y., Kuriakose, E., & Rizvi, N. (2021). P47.07 KEAPSAKE Study of Telaglenastat vs Placebo Plus Standard-of-Care in 1L KEAP1/NRF2-Mutated Non-Squamous Metastatic NSCLC. Journal of Thoracic Oncology, 16(10), S1099. https://doi.org/10.1016/j.jtho.2021.08.500
Authors:
David R. Spigel
Wallace Akerley
Makenzi Colleen Evangelist
Melissa L. Johnson
Benjamin Levy
Taofeek K. Owonikoko
Paul K. Paik
Thales Papagiannakopoulos
Karen L. Reckamp
Lalith Akella
Sacha J. Holland
Yonchu Jenkins
Emil Kuriakose
Naiyer A. Rizvi
Affiliated Authors:
Naiyer A. Rizvi
Subjects:
Advancements in Lung Cancer Research (OpenAlex Topic)
Diagnosis and Treatment of Bladder Cancer (OpenAlex Topic)
Role of Histone Deacetylases in Cellular Regulation (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1016/j.jtho.2021.08.500
DOI:
10.1016/j.jtho.2021.08.500
Journal:
Journal of Thoracic Oncology
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: